- Home
- PROK vs FRGE Comparison
PROK vs FRGE Comparison
Compare PROK & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- FRGE
- Stock Information
- Founded
- PROK 2015
- FRGE 2014
- Country
- PROK United States
- FRGE United States
- Employees
- PROK N/A
- FRGE N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- FRGE Computer Software: Prepackaged Software
- Sector
- PROK Health Care
- FRGE Technology
- Exchange
- PROK Nasdaq
- FRGE Nasdaq
- Market Cap
- PROK 220.6M
- FRGE 207.0M
- IPO Year
- PROK N/A
- FRGE N/A
- Fundamental
- Price
- PROK $1.70
- FRGE $0.84
- Analyst Decision
- PROK Buy
- FRGE Strong Buy
- Analyst Count
- PROK 5
- FRGE 3
- Target Price
- PROK $4.50
- FRGE $4.50
- AVG Volume (30 Days)
- PROK 437.3K
- FRGE 583.7K
- Earning Date
- PROK 11-12-2024
- FRGE 11-06-2024
- Dividend Yield
- PROK N/A
- FRGE N/A
- EPS Growth
- PROK N/A
- FRGE N/A
- EPS
- PROK N/A
- FRGE N/A
- Revenue
- PROK N/A
- FRGE $79,799,000.00
- Revenue This Year
- PROK N/A
- FRGE $19.18
- Revenue Next Year
- PROK N/A
- FRGE $39.61
- P/E Ratio
- PROK N/A
- FRGE N/A
- Revenue Growth
- PROK N/A
- FRGE 18.08
- 52 Week Low
- PROK $1.12
- FRGE $0.83
- 52 Week High
- PROK $4.44
- FRGE $4.02
- Technical
- Relative Strength Index (RSI)
- PROK 43.50
- FRGE 29.41
- Support Level
- PROK $1.95
- FRGE $1.11
- Resistance Level
- PROK $2.27
- FRGE $1.38
- Average True Range (ATR)
- PROK 0.18
- FRGE 0.09
- MACD
- PROK 0.03
- FRGE -0.03
- Stochastic Oscillator
- PROK 26.45
- FRGE 1.35
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The Company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.